In conclusion, our analyses show that the aberrant expression of HIF-1α, PTEN, CD44v6, and Survivin, as measured by IHC, may predict the 5-year overall survival risk and potential for invasion and metastasis in gastric cancer patients, particularly in Asian patients. This evidence concerns the gene HIF1A and gastric cancer.